Literature DB >> 29193659

S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 1: Classification and Diagnosis (ICD10 C82 - C86).

Edgar Dippel1, Chalid Assaf2, Jürgen C Becker3, Michael von Bergwelt-Baildon4, Marc Beyer5, Antonio Cozzio6, Hans Theodor Eich7, Markus Follmann8, Stephan Grabbe9, Uwe Hillen10, Wolfram Klapper11, Claus-Detlev Klemke12, Cristina Lamos1, Carmen Loquai9, Frank Meiß13, Dominik Mestel14, Dorothee Nashan15, Jan P Nicolay16, Ilske Oschlies11, Max Schlaak17, Christoph Stoll18, Tibor Vag19, Michael Weichenthal20, Marion Wobser21, Rudolf Stadler22.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29193659     DOI： 10.1111/ddg.13372

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  6 in total

1.  [Primary cutaneous lymphoma-a case series of 163 patients].

Authors:  D Nashan; C M Friedrich; E Geissler; A Schmitt-Graeff; F Klein; F Meiss
Journal:  Hautarzt       Date:  2018-12       Impact factor: 0.751

2.  [43/m with alopecia and suberythroderma : Preparation for the specialist examination: part 9].

Authors:  Rose K C Moritz
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

3.  Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients.

Authors:  Marion Wobser; Sabine Roth; Silke Appenzeller; Hermann Kneitz; Matthias Goebeler; Eva Geissinger; Andreas Rosenwald; Katja Maurus
Journal:  JID Innov       Date:  2021-06-15

4.  De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma.

Authors:  Michael Oertel; Khaled Elsayad; Carsten Weishaupt; Kerstin Steinbrink; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2019-11-22       Impact factor: 3.621

5.  European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1.

Authors:  R Knobler; P Arenberger; A Arun; C Assaf; M Bagot; G Berlin; A Bohbot; P Calzavara-Pinton; F Child; A Cho; L E French; A R Gennery; R Gniadecki; H P M Gollnick; E Guenova; P Jaksch; C Jantschitsch; C Klemke; J Ludvigsson; E Papadavid; J Scarisbrick; T Schwarz; R Stadler; P Wolf; J Zic; C Zouboulis; A Zuckermann; H Greinix
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-10-06       Impact factor: 6.166

6.  Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome.

Authors:  Georg-Nikolaus Franke; Konstantin Dumann; Madlen Jentzsch; Astrid Monecke; Christine Doehring; Claudia Nehring-Vucinic; Sebastian Schwind; Dietger Niederwieser; Uwe Platzbecker; Mirjana Ziemer; Vladan Vucinic
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.